Abstract
Aldose reductase, the key enzyme of the polyol pathway, is known to play important roles in the diabetic complication. The inhibitors of aldose reductase, therefore, would be potential agents for the prevention of diabetic complications. To evaluate active principles for the inhibition of aldose reductase from the rhizomes ofBelamcanda chinensis, twelve phenolic compounds were isolated and tested for their effects on rat lens aldose reductase. As a result, isoflavones such as tectorigenin, irigenin and their glucosides were found to show a strong aldose reductase inhibition. Tectoridin and tectorigenin, exhibited the highest aldose reductase inhibitory potency, their IC50 values, being 1.08x 10-6 M and 1.12 x 10-6 M, respectively, for DL-glyceraldehyde as a substrate. Both compounds, when administered orally at 100 mg/kg for 10 consecutive days to streptozotocin-induced diabetic rats, caused a significant inhibition of sorbitol accumulation in the tissues such as lens, sciatic nerves and red blood cells. Tectorigenin showed a stronger inhibitory activity than tectoridin. From these results, it is suggested that tectorigenin is attributed to be a promising compound for the prevention and/or treatment of diabetic complications.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aida, K., Tawata, M., Shindo, H., Tsukahara, S. and Onaya, T., Effects of anti-inflammatory drugs and ONO-2235 on lens aldose reductase and on sorbitol accumulation in red blood cells.Yamanashi Med., 3, 47–56 (1988).
Aida, K., Tawata, M., Shindo, H., Onaya, T., Sasaki, H., Yamaguchi, T., Chin, M. and Mitsuhashi, H., Isoliquiriti genin: A new aldose reductase inhibitor from Glycyrrhizae Radix.Planta Med., 57, 254–258 (1990).
Beyer-Mears, A. Ku, L. and Cohen, M., Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.Diabetes, 33, 604–607 (1984).
Beyer-Mears, A. and Cruz, E., Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.Diabetes, 34, 15–21 (1985).
Engerman, R. L. and Kem, T. S., Experimental galactosemia produces diabetic-like retinopathy.Diabetes, 33, 97–100 (1984).
Handelsman D. J. and Turtle J.R., Clinical trial of an aldose reductase inhibitor in diabetic neuropathy.Diabetes, 30, 459–464 (1981).
Hayman, S. and Kinoshita, J. H., Isolation and properties of lens aldose reductase.J. Biol. Chem., 240, 877–882 (1965).
Inagaki, K., Miwa, I. and Okuda, J., Affinity purification and glucose specificity of aldose reductase from bovine lens.Arch. Biochem. Biophys., 216, 337–344 (1982).
Kinoshita, J. H., Mechanism initiating cataract formation.Invest. Ophthalmol., 13, 713–723 (1974).
Kinoshita, J. H., Fukushi, S., Kador, P. and Merola, L. O., Aldose reductase in diabetic complications of the eye.Metabolism, 28, 462–469 (1979).
Malone, J. I., Knox, G., Benford, S., Tedesco, T. A., Red cell sorbitol: an indicator of diabetic control.Diabetes, 29, 861–864 (1980).
Raskin, P. and Rosentstock, J., Aldose reductase inhibitors and diabetic complications.Am. J. Med., 83, 298–306 (1987).
Yamaki, M., Kato, T., Kashihara, M. and Takagi, S., Isoflavones fromBelamcanda chinensis. Planta Med., 56, 335 (1990).
Okuda, J., Miwa, I., Inagaki, K., Horie, T. and Nakayama, M., Inhibition of aldose reductases from rat and bovine lenses by flavonoids.Biochem. Pharm., 31, 3807–3822 (1982).
Sato, S. and Kador, P. F. Inhibition of aldehyde reductase by aldose reductase inhibitors.Biochem. Pharmacol., 40, 1033–1042 (1990).
Shimizu, M., Ito, T., Terashima, S., Hayashi, T., Arisawa, M., Morita, N., Kurokawa, S., Ito, K. and Hashimoto, Y., Inhibi- tion of lens aldose reductase by flavonoids.Phytochemistry, 23, 1885–1888 (1984).
Shin, K. H., Chung, M. S., Chae, Y. J., Yoon, K. Y. and Cho, T. S., A survey for aldose reductase inhibition of some herbal medicines.Fitoterapia, 14, 130 (1993).
Shin, K. H., Kang, S. S., Kim, H. J. and Shin, S. W., Isolation of an aldose reductase inhibitor from the fruits ofVitex rotundifolia. Phytomed., 1, 145–147 (1994).
Shin, K. H., Kang, S. S., Seo, E. A. and Shin, S. W., Isolation of aldose reductase inhibitors from the flowers ofChrysan- themum boreale. Arch. Pharm. Res., 18, 65–68 (1995).
Terashima, H., Hama, K., Yamamoto, R., Tsuboshima, M., Kikkawa, R., Hatanaka, J. and Shigeta, Y., Effects of a new aldose reductase inhibitor on various tissuesin vitro. J. Pharm. Exp. Ther., 229, 226–230 (1984).
Van Heyningen, R., Formation of polyol by the lens of the rat with sugar cataract.Nature, 184, 194–196 (1959).
Van Heyningen, R., The polyol pathway in the neuropathy of early diabetes. In “dvances in Metabolic Disorders (Suppl. 2)” ed. By R. A. Camerini-Davalos and H. S. Cole, Academic Press, New York, pp. 425 (1973).
Varma, S. D. and Kinoshita, J. H., Inhibition of lens aldose reductase by flavonoids-their possible role in the prevention of diabetic cataracts.Biochem. Pharm., 25, 2505–2513 (1976).
Ward, J. D., The polyol pathway in the neuropathy of early diabetes. In “dvance in Metabolic Disorders (Suppl. 2)” ed. By R. A. Camerini-Davalos and H. S. Cole, Academic Press, New York, pp. 425 (1973).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jung, S.H., Lee, Y.S., Lee, S. et al. Isoflavonoids from the rhizomes ofBelamcanda chinensis and their effects on aldose reductase and sorbitol accumulation in streptozotocin induced diabetic rat tissues. Arch Pharm Res 25, 306–312 (2002). https://doi.org/10.1007/BF02976631
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02976631